{"cdcTestId":"2013-0296","testcaseName":"dose 1 to 2, interval 4 weeks -5 days","vaccineGroup":"HIB","evaluationTestType":"Interval: Below Absolute Minimum","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-07-26T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-09-26T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Not Valid","evaluationReason":"Interval: too short"}]},"forecast":{"forecastNum":"2","earliestDate":"2022-11-16T00:00:00","recommendedDate":"2022-11-26T00:00:00","pastDueDate":"2023-01-22T00:00:00"},"doses":[{"dateAdministered":"2022-09-26T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"ACTHIB","cvx":"48","mvx":"PMC","evaluationStatus":"Not Valid","evaluationReason":"Interval: too short"}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-05-22T12:04:56.88","generalDescription":"This test case describes when a child is administered the second dose of the Hib vaccine at an interval of 4 weeks - 5 days that the dose is Extraneous.  No further does should be forecast.  The series is complete.","changedInVersion":"1.0","reasonForChange":""}